• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病亚洲患者肠道微生物群、肥胖、身体成分与胰岛素抵抗的相互关系

Interrelationship of Gut Microbiota, Obesity, Body Composition and Insulin Resistance in Asians with Type 2 Diabetes Mellitus.

作者信息

Pai Che-Sheng, Wang Cheng-Yuan, Hung Wei-Wen, Hung Wei-Chun, Tsai Hui-Ju, Chang Chen-Chia, Hwang Shang-Jyh, Dai Chia-Yen, Ho Wen-Yu, Tsai Yi-Chun

机构信息

Department of Internal Medicine, Division of Endocrinology and Metabolism, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

Department of Internal Medicine, Division of General Medicine, Kaohsiung Medical University, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.

出版信息

J Pers Med. 2022 Apr 11;12(4):617. doi: 10.3390/jpm12040617.

DOI:10.3390/jpm12040617
PMID:35455732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9025506/
Abstract

Metabolic syndrome (MS) has been an important health issue in the world, and insulin resistance (IR) is one of the characteristics of MS, increasing the risk for the onset and poor prognosis of type 2 diabetes mellitus (T2D). However, the interactional effect of obesity or abnormal body composition on the correlation between gut microbiota and IR in T2D patients is not well-explored. This cross-sectional study used a body composition monitor to evaluate lean tissue mass and fat tissue mass. IR was calculated using homeostatic model assessment-insulin resistance (HOMA-IR). Eight pairs of 16S rRNA gene primers specific to , , group, , , , , and were utilized to measure their abundance by qPCR. One hundred and fifty-four T2D patients were enrolled and stratified by the median HOMA-IR (2.5) and body mass index (BMI) of 25 kg/m. A lower abundance of was found in T2D patients with high HOMA-IR and BMI respectively. HOMA-IR and BMI had a synergistic effect on the reduction of the abundance of . After adjusting metabolic factors, the low abundance of significantly increased the risk for greater severity of IR. Furthermore, the negative correlation between and IR was only found in T2D patients with high lean tissue. In conclusion, decreased abundance of fecal enhanced the severity of IR in Asians with T2D, especially those having lean mass, and this significant relationship was independent of obesity.

摘要

代谢综合征(MS)一直是全球重要的健康问题,胰岛素抵抗(IR)是MS的特征之一,会增加2型糖尿病(T2D)发病及预后不良的风险。然而,肥胖或身体成分异常对T2D患者肠道微生物群与IR之间相关性的交互作用尚未得到充分研究。这项横断面研究使用身体成分监测仪评估瘦组织质量和脂肪组织质量。采用稳态模型评估胰岛素抵抗(HOMA-IR)计算IR。使用八对分别针对 、 、 组、 、 、 、 、 和 的16S rRNA基因引物,通过qPCR测量它们的丰度。纳入154例T2D患者,并根据HOMA-IR中位数(2.5)和体重指数(BMI)25 kg/m²进行分层。分别在HOMA-IR和BMI较高的T2D患者中发现 丰度较低。HOMA-IR和BMI对 丰度的降低具有协同作用。调整代谢因素后, 丰度低显著增加了IR更严重的风险。此外,仅在瘦组织含量高的T2D患者中发现 与IR呈负相关。总之,粪便中 丰度降低会加重亚洲T2D患者的IR严重程度,尤其是那些瘦体重者,且这种显著关系独立于肥胖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c97/9025506/64d24d224860/jpm-12-00617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c97/9025506/64d24d224860/jpm-12-00617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c97/9025506/64d24d224860/jpm-12-00617-g001.jpg

相似文献

1
Interrelationship of Gut Microbiota, Obesity, Body Composition and Insulin Resistance in Asians with Type 2 Diabetes Mellitus.2型糖尿病亚洲患者肠道微生物群、肥胖、身体成分与胰岛素抵抗的相互关系
J Pers Med. 2022 Apr 11;12(4):617. doi: 10.3390/jpm12040617.
2
Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients.2型糖尿病患者的肠道微生物群与非酒精性脂肪性肝病严重程度
J Pers Med. 2021 Mar 23;11(3):238. doi: 10.3390/jpm11030238.
3
The Association of Targeted Gut Microbiota with Body Composition in Type 2 Diabetes Mellitus.靶向肠道微生物群与 2 型糖尿病患者体成分的相关性研究。
Int J Med Sci. 2021 Jan 1;18(2):511-519. doi: 10.7150/ijms.51164. eCollection 2021.
4
Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes.瘦型 2 型糖尿病中阿克曼氏菌属黏液亚种丰度降低导致胰岛素分泌受损和葡萄糖内稳态紊乱。
Adv Sci (Weinh). 2021 Aug;8(16):e2100536. doi: 10.1002/advs.202100536. Epub 2021 Jun 4.
5
Berberis kansuensis extract alleviates type 2 diabetes in rats by regulating gut microbiota composition.宁夏小檗提取物通过调节肠道微生物组成缓解大鼠 2 型糖尿病。
J Ethnopharmacol. 2021 Jun 12;273:113995. doi: 10.1016/j.jep.2021.113995. Epub 2021 Mar 4.
6
Mucosa-associated microbiota in the jejunum of patients with morbid obesity: alterations in states of insulin resistance and metformin treatment.肥胖症患者空肠黏膜相关菌群:胰岛素抵抗状态和二甲双胍治疗的改变。
Surg Obes Relat Dis. 2020 Oct;16(10):1575-1585. doi: 10.1016/j.soard.2020.04.008. Epub 2020 Apr 18.
7
Faecal levels of Bifidobacterium and Clostridium coccoides but not plasma lipopolysaccharide are inversely related to insulin and HOMA index in women.粪便中产双歧杆菌和梭菌 coccoides 的水平与女性的胰岛素和 HOMA 指数呈负相关,但与血浆脂多糖无关。
Clin Nutr. 2013 Dec;32(6):1017-22. doi: 10.1016/j.clnu.2013.02.008. Epub 2013 Feb 21.
8
Role of Akkermansia muciniphila in insulin resistance.嗜黏蛋白阿克曼氏菌在胰岛素抵抗中的作用。
J Gastroenterol Hepatol. 2025 Jan;40(1):19-32. doi: 10.1111/jgh.16747. Epub 2024 Oct 13.
9
Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus.肠道微生物群与 2 型糖尿病患者的亚临床心血管疾病。
Nutrients. 2021 Aug 1;13(8):2679. doi: 10.3390/nu13082679.
10
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.阿克曼氏菌与肠道上皮细胞的串扰控制饮食诱导的肥胖。
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9066-71. doi: 10.1073/pnas.1219451110. Epub 2013 May 13.

引用本文的文献

1
The functional landscape of the appendix microbiome under conditions of health and disease.健康与疾病状态下阑尾微生物群的功能图谱。
Gut Pathog. 2025 Jun 1;17(1):38. doi: 10.1186/s13099-025-00696-2.
2
: A promising probiotic against inflammation and metabolic disorders.一种有前途的针对炎症和代谢紊乱的益生菌。
Virulence. 2024 Dec;15(1):2375555. doi: 10.1080/21505594.2024.2375555. Epub 2024 Aug 27.
3
Cardiometabolic Risk: Characteristics of the Intestinal Microbiome and the Role of Polyphenols.心血管代谢风险:肠道微生物群的特征及多酚的作用

本文引用的文献

1
Fat-free/lean body mass in children with insulin resistance or metabolic syndrome: a systematic review and meta-analysis.儿童胰岛素抵抗或代谢综合征患者的去脂/去脂体重:系统评价和荟萃分析。
BMC Pediatr. 2022 Jan 22;22(1):58. doi: 10.1186/s12887-021-03041-z.
2
Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus.肠道微生物群与 2 型糖尿病患者的亚临床心血管疾病。
Nutrients. 2021 Aug 1;13(8):2679. doi: 10.3390/nu13082679.
3
a New Generation of Beneficial Microbiota in Modulating Obesity: A Systematic Review.
Int J Mol Sci. 2023 Sep 6;24(18):13757. doi: 10.3390/ijms241813757.
4
Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment.药物微生物组学与 2 型糖尿病:一种新的治疗视角。
Front Endocrinol (Lausanne). 2023 Mar 23;14:1149256. doi: 10.3389/fendo.2023.1149256. eCollection 2023.
5
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes.瘦型/正常体重 2 型糖尿病的病理生理学的现有知识。
Int J Mol Sci. 2022 Dec 30;24(1):658. doi: 10.3390/ijms24010658.
6
Gut microbiota and obesity: New insights.肠道微生物群与肥胖:新见解
Front Nutr. 2022 Oct 14;9:1018212. doi: 10.3389/fnut.2022.1018212. eCollection 2022.
7
Association between body weight and distal gut microbes in Hainan black goats at weaning age.断奶期海南黑山羊体重与远端肠道微生物之间的关联
Front Microbiol. 2022 Sep 16;13:951473. doi: 10.3389/fmicb.2022.951473. eCollection 2022.
8
Development of the gut microbiota in healthy twins during the first 2 years of life and associations with body mass index z-score: Results from the Wuhan twin birth cohort study.武汉双胎出生队列研究:健康双胞胎出生后2年内肠道微生物群的发育及其与体重指数Z评分的关联
Front Microbiol. 2022 Aug 18;13:891679. doi: 10.3389/fmicb.2022.891679. eCollection 2022.
新一代有益微生物群在调节肥胖中的作用:一项系统综述。
Microorganisms. 2021 May 20;9(5):1098. doi: 10.3390/microorganisms9051098.
4
Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients.2型糖尿病患者的肠道微生物群与非酒精性脂肪性肝病严重程度
J Pers Med. 2021 Mar 23;11(3):238. doi: 10.3390/jpm11030238.
5
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
6
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
7
Gut microbiota in human metabolic health and disease.人体肠道微生物群与代谢健康和疾病。
Nat Rev Microbiol. 2021 Jan;19(1):55-71. doi: 10.1038/s41579-020-0433-9. Epub 2020 Sep 4.
8
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression.肠道微生物群发酵途径在脂肪肝疾病进展中的作用
J Clin Med. 2020 May 7;9(5):1369. doi: 10.3390/jcm9051369.
9
Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer's disease.阿克曼氏菌对阿尔茨海默病小鼠模型认知缺陷和淀粉样蛋白病理的保护作用。
Nutr Diabetes. 2020 Apr 22;10(1):12. doi: 10.1038/s41387-020-0115-8.
10
Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease.脂肪组织分布、炎症及其代谢后果,包括糖尿病和心血管疾病。
Front Cardiovasc Med. 2020 Feb 25;7:22. doi: 10.3389/fcvm.2020.00022. eCollection 2020.